Published in Gastroenterology on May 27, 2010
Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol (2011) 2.49
Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol (2013) 1.55
Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology (2012) 1.44
An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol (2013) 1.02
Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One (2013) 0.98
Can quality of care for patients with cirrhosis be measured? Dig Dis Sci (2011) 0.95
Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci (2013) 0.83
Identifying cirrhosis patients for intensive disease management. Dig Dis Sci (2013) 0.79
How can we improve quality of care for patients with cirrhosis? Gastroenterology (2012) 0.75
Patient-perceived barriers to lifestyle interventions in cirrhosis. Saudi J Gastroenterol (2017) 0.75
Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis. Ann Gastroenterol (2016) 0.75
Disability in Patients with End-Stage Liver Disease: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver Transpl (2016) 0.75
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
Diabetes control with reciprocal peer support versus nurse care management: a randomized trial. Ann Intern Med (2010) 5.18
The health effects of restricting prescription medication use because of cost. Med Care (2004) 3.65
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology (2010) 3.53
Management of hepatitis B: summary of a clinical research workshop. Hepatology (2007) 3.40
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology (2010) 3.35
The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care (2005) 3.11
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology (2009) 3.10
Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med (2007) 2.94
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology (2002) 2.79
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol (2008) 2.66
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63
Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J (2003) 2.61
National standards for diabetes self-management education. Diabetes Care (2008) 2.60
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev (2012) 2.57
Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials. Diabetes Care (2007) 2.50
The effect of chronic pain on diabetes patients' self-management. Diabetes Care (2005) 2.48
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology (2008) 2.44
An online community improves adherence in an internet-mediated walking program. Part 1: results of a randomized controlled trial. J Med Internet Res (2010) 2.43
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol (2010) 2.38
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
National standards for diabetes self-management education. Diabetes Care (2009) 2.36
National standards for diabetes self-management education. Diabetes Care (2012) 2.36
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology (2002) 2.34
Physician notification of their diabetes patients' limited health literacy. A randomized, controlled trial. J Gen Intern Med (2005) 2.31
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol (2005) 2.26
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25
National standards for diabetes self-management education. Diabetes Care (2007) 2.21
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology (2004) 2.09
Noninvasive monitoring of patients with chronic hepatitis C. Hepatology (2002) 2.08
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology (2006) 2.06
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care (2010) 2.05
Preferences for self-management support: findings from a survey of diabetes patients in safety-net health systems. Patient Educ Couns (2007) 2.04
Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol (2005) 2.04
Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care (2007) 2.02
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology (2011) 1.98
National standards for diabetes self-management education. Diabetes Care (2010) 1.96
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology (2008) 1.95
HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology (2002) 1.88
A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol (2009) 1.86
Interactive behavior change technology. A partial solution to the competing demands of primary care. Am J Prev Med (2004) 1.84
Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83
Clinical significance of hepatitis B virus genotypes. Hepatology (2002) 1.82
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut (2010) 1.78
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology (2006) 1.76
Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology (2006) 1.76
Interactive behavior change technology to support diabetes self-management: where do we stand? Diabetes Care (2007) 1.73
Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl (2008) 1.72
National standards for diabetes self-management education and support. Diabetes Care (2013) 1.70
National standards for diabetes self-management education and support. Diabetes Care (2014) 1.70
Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr Serv (2005) 1.69
Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv (2009) 1.68
A randomized trial comparing structured and lifestyle goals in an internet-mediated walking program for people with type 2 diabetes. Int J Behav Nutr Phys Act (2007) 1.65
Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl (2007) 1.64
Efficacy of peer support interventions for depression: a meta-analysis. Gen Hosp Psychiatry (2010) 1.63
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl (2007) 1.61
National Standards for diabetes self-management education. Diabetes Care (2011) 1.60
"I help you, and you help me": facilitated telephone peer support among patients with diabetes. Diabetes Educ (2005) 1.59
National standards for diabetes self-management education and support. Diabetes Care (2012) 1.59
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care (2008) 1.57
Indications for therapy in hepatitis B. Hepatology (2009) 1.57
Depression increases diabetes symptoms by complicating patients' self-care adherence. Diabetes Educ (2004) 1.54
The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis (2010) 1.53
Validation of prognostic models among patients with advanced heart failure. J Card Fail (2006) 1.53
Randomized controlled effectiveness trial of reciprocal peer support in heart failure. Circ Heart Fail (2013) 1.51
Family influences on self-management among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help? Chronic Illn (2010) 1.50
Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord (2008) 1.48
When to start and stop hepatitis B treatment: can one set of criteria apply to all patients regardless of age at infection? Ann Intern Med (2007) 1.48
Prevalence of HBV precore/core promoter variants in the United States. Hepatology (2003) 1.47
Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.46
Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol (2003) 1.45
Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology (2012) 1.44
Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol (2003) 1.43
Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. Am J Manag Care (2007) 1.42
Clinical decisions. Management of incidental hepatitis C virus infection. N Engl J Med (2009) 1.42
The impact of family behaviors and communication patterns on chronic illness outcomes: a systematic review. J Behav Med (2011) 1.40
Emerging models for mobilizing family support for chronic disease management: a structured review. Chronic Illn (2010) 1.38
Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care (2007) 1.37
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology (2009) 1.35
Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res (2009) 1.33
Newer markers for hepatocellular carcinoma. Gastroenterology (2004) 1.31
Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law (2008) 1.31
Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications? J Behav Med (2005) 1.28
Clinician identification of chronically ill patients who have problems paying for prescription medications. Am J Med (2004) 1.27
The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol (2015) 1.25
The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment. Addict Behav (2003) 1.25
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir. J Clin Microbiol (2006) 1.25
Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology (2012) 1.25
Integrating support persons into diabetes telemonitoring to improve self-management and medication adherence. J Gen Intern Med (2014) 1.19
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol (2002) 1.19
Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol (2009) 1.18
Self-efficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus. Diabetes Educ (2008) 1.16
"I am not alone": the feasibility and acceptability of interactive voice response-facilitated telephone peer support among older adults with heart failure. Congest Heart Fail (2007) 1.16
Experience and management of chronic pain among patients with other complex chronic conditions. Clin J Pain (2009) 1.14
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology (2006) 1.13
Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci (2010) 1.12